MMR Vaccine Supply and Delivery for Overseas Military Vessel

The contract entails the supply and cold chain delivery of a single unit of the Measles, Mumps, and Rubella (MMR) vaccine to a U.S. Navy vessel operating overseas, under strict regulatory and logistical protocols. The vaccine must be FDA-licensed and handled with uncompromising temperature control throughout transit to ensure potency and safety, with zero tolerance for any deviation in quantity or condition. Delivery must be executed via traceable express shipping methods to guarantee secure, timely arrival and full supply chain accountability. This subcontract, managed by the Defense Logistics Agency under the Department of Defense, falls under NAICS code 325412 for pharmaceutical and medicine manufacturing. The effort supports the health readiness of military personnel in austere environments, where access to medical supplies is limited. All aspects of fulfillment—from sourcing to final delivery—are governed by federal standards for vaccine distribution, requiring documentation and verification at every stage. The contract emphasizes precision, compliance, and reliability, with no flexibility permitted for delays, temperature excursions, or discrepancies in volume.